Microbiota, epidemiological and nutritional factors related to ketoacidosis at the onset of type 1 diabetes.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 25 02 2020
accepted: 28 05 2020
pubmed: 1 7 2020
medline: 15 12 2020
entrez: 29 6 2020
Statut: ppublish

Résumé

The incidence of type 1 diabetes has increased over the last decades. The pathological pathway is not yet clear, even if genetic and environmental risk factors are known. An early diagnosis can avoid ketoacidosis and its complications. This work aims to discuss the determinants of both ketoacidosis at the onset and access by hospital emergency departments without a suspected diagnosis. An observational bi-centric prospective study was conducted in Northern Italy, on a paediatric population including Italian and migrant patients at the diabetes onset. Seventy-four type 1 diabetes patients, both Italian and migrant, were included in the study. Anthropometric, socio-economic, behavioural, clinical data were collected, and microbiota analyses were performed using stool samples. Regular physical activity is associated with lower ketoacidosis incidence at onset (OR 0.33 95% CI 0.12-0.95 p < 0.05), as is higher blood vitamin D level (OR 0.92 95% CI 0.85-0.99 p < 0.05). Moreover, a higher weaning age (OR 0.49 95% CI 0.27-0.89 p < 0.05), higher vitamin D level (OR 0.90 95% CI 0.83-0.98 p < 0.05) and a higher level of Akkermansia muciniphila (OR 0.46 95% CI 0.25-0.87 p < 0.05) are associated factors to lower frequency of type 1 diabetes onset without a suspected diagnosis. Diabetes migrant status is not a risk factor for severe type 1 diabetes onset; on the other hand, some protective factors are significantly more diffused among Italians, such as regular sport activity and non-critical vitamin D levels. Behavioural and nutritional data, such as microbiota bio-indicators, seem to be useful to identify an at-risk population to prevent ketoacidosis and its severe complications.

Identifiants

pubmed: 32594251
doi: 10.1007/s00592-020-01555-z
pii: 10.1007/s00592-020-01555-z
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1337-1349

Références

World Health Organization—Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention, Geneva, Switzerland (2019) Classification of diabetes mellitus 2019 https://www.who.int/health-topics/diabetes
National Center for Chronic Disease Prevention and Health Promotion (2017) National Diabetes Statistics Report, 2017. Estimates of diabetes and its burden in the United States.
Patterson CC, Harjutsalo V, Rosenbauer J et al (2019) Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study. Diabetologia 62:408–417. https://doi.org/10.1007/s00125-018-4763-3
doi: 10.1007/s00125-018-4763-3 pubmed: 30483858
Bruno G (2016) Il registro diabete Piemonte. Italian Health Policy Brief. Anno VI Speciale, pp. 1–8
Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82. https://doi.org/10.1016/S0140-6736(13)60591-7
doi: 10.1016/S0140-6736(13)60591-7 pubmed: 23890997
Dedrick S, Sundaresh B, Huang Q et al (2020) The role of gut microbiota and environmental factors in type 1 diabetes pathogenesis. Front Endocrinol (Lausanne) 11:1–20. https://doi.org/10.3389/fendo.2020.00078
doi: 10.3389/fendo.2020.00078
Knip M, Luopajärvi K, Härkönen T (2017) Early life origin of type 1 diabetes. Semin Immunopathol 39:653–667. https://doi.org/10.1007/s00281-017-0665-6
doi: 10.1007/s00281-017-0665-6 pubmed: 29170800
Park A, Zhao G (2018) Mining the Virome for Insights into Type 1 Diabetes. DNA Cell Biol 37:422–425. https://doi.org/10.1089/dna.2018.4185
doi: 10.1089/dna.2018.4185 pubmed: 29638163 pmcid: 5944395
Paschou SA, Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C (2018) On type 1 diabetes mellitus pathogenesis. Endocr Connect 7:R38–R46. https://doi.org/10.1530/EC-17-0347
doi: 10.1530/EC-17-0347 pubmed: 29191919
Zipitis CS, Akobeng AK (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93:512–517
doi: 10.1136/adc.2007.128579
Feng R, Li Y, Li G et al (2015) Lower serum 25 (OH) D concentrations in type 1 diabetes: a meta-analysis. Diabetes Res Clin Pract 108:e71–e75. https://doi.org/10.1016/j.diabres.2014.12.008
doi: 10.1016/j.diabres.2014.12.008 pubmed: 25836943
Giri D, Pintus D, Burnside G et al (2017) Treating vitamin D deficiency in children with type 1 diabetes could improve their glycaemic control. BMC Res Notes. https://doi.org/10.1186/s13104-017-2794-3
doi: 10.1186/s13104-017-2794-3 pubmed: 28882195 pmcid: 5590233
Rewers M, Ludvigsson J (2016) Environmental risk factors for type 1 diabetes. Lancet 387:2340–2348
doi: 10.1016/S0140-6736(16)30507-4
Bizzarri C, Pitocco D, Napoli N et al (2010) No protective effect of calcitriol on β-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 33:1962–1963. https://doi.org/10.2337/dc10-0814
doi: 10.2337/dc10-0814 pubmed: 20805274 pmcid: 2928344
Cashen K, Petersen T (2019) Diabetic ketoacidosis. Pediatr Rev 40:412–420. https://doi.org/10.1542/pir.2018-0231
doi: 10.1542/pir.2018-0231 pubmed: 31371634
Rabbone I, Maltoni G, Tinti D et al (2019) Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0–18 years. Arch Dis Child. https://doi.org/10.1136/archdischild-2019-316903
doi: 10.1136/archdischild-2019-316903 pubmed: 31597646
World Health Organization (2018) Template for Parental Consent-clinical studies 20, avenue Appia – CH-1211 Geneva 27 – Switzerland. http://www.who.int/ethics/review-committee
Franzosa EA, Morgan XC, Segata N et al (2014) Relating the metatranscriptome and metagenome of the human gut. PNAS 111:E2329–E2338. https://doi.org/10.1073/pnas.1319284111
doi: 10.1073/pnas.1319284111 pubmed: 24843156
IHMS Consortium (2015) IHMS-SOP 02 V2: Standard Operating Procedure for Fecal Samples Self ‐ Collection Laboratory Analysis Handled Within 4 To 24 Hour. http://www.microbiome-standards.org/index.php?id=289
Wolfsdorf JI, Glaser N, Agus M et al (2018) ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 19:155–177. https://doi.org/10.1111/pedi.12701
doi: 10.1111/pedi.12701 pubmed: 29900641
Istituto Superiore di Sanità (2017) Sovrappeso e obesità infantile, i dati del Sistema di Sorveglianza OKkio alla Salute. http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=2929
Verduci E, Radaelli G, Stival G et al (2007) Dietary macronutrient intake during the first 10 years of life in a cohort of Italian children. J Pediatr Gastroenterol Nutr 45:90–95. https://doi.org/10.1097/MPG.0b013e318058ca4e
doi: 10.1097/MPG.0b013e318058ca4e pubmed: 17592370
Meek RL, LeBoeuf RC, Saha SA et al (2013) Glomerular cell death and inflammation with high-protein diet and diabetes. Nephrol Dial Transplant 28:1711–1720. https://doi.org/10.1093/ndt/gfs579
doi: 10.1093/ndt/gfs579 pubmed: 23314315 pmcid: 3707525
Gunn ER, Albert BB, Hofman PL et al (2017) Pathways to reduce diabetic ketoacidosis with new onset type 1 diabetes: evidence from a regional pediatric diabetes center: Auckland, New Zealand, 2010 to 2014. Pediatr Diabetes 18:553–558. https://doi.org/10.1111/pedi.12456
doi: 10.1111/pedi.12456 pubmed: 27726271
Borgo F, Verduci E, Riva A et al (2017) Relative abundance in bacterial and fungal gut microbes in obese children: a case control study. Child Obes 13:78–84. https://doi.org/10.1089/chi.2015.0194
doi: 10.1089/chi.2015.0194 pubmed: 27007700
Szypowska A, Dżygało K, Wysocka-Mincewicz M et al (2017) High incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes among polish children aged 10–12 and under 5 years of age: a multicenter study. Pediatr Diabetes 18:722–728. https://doi.org/10.1111/pedi.12446
doi: 10.1111/pedi.12446 pubmed: 27726262
Lee HJ, Yu HW, Jung HW et al (2017) Factors associated with the presence and severity of diabetic ketoacidosis at diagnosis of type 1 diabetes in korean children and adolescents. @bull J Korean Med Sci 32:303–309. https://doi.org/10.3346/jkms.2017.32.2.303
doi: 10.3346/jkms.2017.32.2.303
Cherubini V, Skrami E, Ferrito L et al (2019) Exercise has the guts: How physical activity may positively modulate gut microbiota in chronic and immune-based diseases. Dig Liver Dis 62:1–4. https://doi.org/10.1007/s00125-018-4763-3
doi: 10.1007/s00125-018-4763-3
Vecchio F, Lo BN, Stabilini A et al (2018) Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes federica vecchio, …, the type 1 diabetes trialnet study group, manuela battaglia find the latest version : abnormal neutrophil signature in the bl. JCI Insight 3:1–17. https://doi.org/10.1172/JCI.INSIGHT.122146
doi: 10.1172/JCI.INSIGHT.122146
Muyzer G, Waal ECDE, Uitierlinden AG (1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Applaied Environ Microbiol 59:695–700
doi: 10.1128/AEM.59.3.695-700.1993
Vanhoutte T, Huys G, De Brandt E, Swings J (2004) Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48:437–446. https://doi.org/10.1016/j.femsec.2004.03.001
doi: 10.1016/j.femsec.2004.03.001 pubmed: 19712312
Joossens M, Huys G, Van Steen K et al (2011) High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake. FEMS Microbiol Ecol 75:343–349. https://doi.org/10.1111/j.1574-6941.2010.01008.x
doi: 10.1111/j.1574-6941.2010.01008.x pubmed: 21133959
De Goffau MC, Luopajärvi K, Knip M et al (2013) Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 62:1238–1244. https://doi.org/10.2337/db12-0526
doi: 10.2337/db12-0526 pubmed: 23274889 pmcid: 3609581
Davis-Richardson AG, Ardissone AN, Dias R et al (2014) Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol 5:1–11. https://doi.org/10.3389/fmicb.2014.00678
doi: 10.3389/fmicb.2014.00678
Brown CT, Davis-Richardson AG, Giongo A et al (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6:1–9. https://doi.org/10.1371/journal.pone.0025792
doi: 10.1371/journal.pone.0025792
Ottman N, Reunanen J, Meijerink M et al (2017) Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS ONE 12:1–18. https://doi.org/10.1371/journal.pone.0173004
doi: 10.1371/journal.pone.0173004
Cani PD (2018) Severe obesity and gut microbiota: does bariatric surgery really reset the system? Gut gutjnl-2018-316815. https://doi.org/10.1136/gutjnl-2018-316815
Knight R, Vrbanac A, Taylor BC et al (2018) Best practices for analysing microbiomes. Nat Rev Microbiol. https://doi.org/10.1038/s41579-018-0029-9
doi: 10.1038/s41579-018-0029-9 pubmed: 29795328
Webster NS, Negri AP (2006) Site-specific variation in Antarctic marine biofilms established on artificial surfaces. Environ Microbiol 8:1177–1190. https://doi.org/10.1111/j.1462-2920.2006.01007.x
doi: 10.1111/j.1462-2920.2006.01007.x pubmed: 16817926
O’Sullivan LA, Webster G, Fry JC et al (2008) Modified linker-PCR primers facilitate complete sequencing of DGGE DNA fragments. J Microbiol Methods 75:579–581. https://doi.org/10.1016/j.mimet.2008.08.006
doi: 10.1016/j.mimet.2008.08.006 pubmed: 18789360
Dridi B, Henry M, El Khéchine A et al (2009) High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS ONE 4:e7063. https://doi.org/10.1371/journal.pone.0007063
doi: 10.1371/journal.pone.0007063 pubmed: 2738942 pmcid: 2738942
Guo X, Xia X, Tang R et al (2008) Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 47:367–373. https://doi.org/10.1111/j.1472-765X.2008.02408.x
doi: 10.1111/j.1472-765X.2008.02408.x pubmed: 19146523
Murri M, Leiva I, Gomez-zumaquero JM, et al (2013) Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med 11:46. http://www.biomedcentral.com/1741-7015/11/46
Nakayama T, Oishi K (2013) Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. FEMS microbial lett 343(2):161–168
doi: 10.1111/1574-6968.12142
Matsuki T, Watanabe K, Fujimoto J et al (2004) Quantitative pcr with 16s primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70:167–173. https://doi.org/10.1128/AEM.70.1.167
doi: 10.1128/AEM.70.1.167 pubmed: 14711639 pmcid: 321263
Dao MC, Everard A, Aron-wisnewsky J et al (2016) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity : relationship with gut microbiome richness and ecology. Gut microbiota 65:426–436. https://doi.org/10.1136/gutjnl-2014-308778
doi: 10.1136/gutjnl-2014-308778
Johnston C, Ufnar JA, Griffith JF et al (2010) A real-time qPCR assay for the detection of the nifH gene of Methanobrevibacter smithii, a potential indicator of sewage pollution. J Appl Microbiol 109:1946–1956. https://doi.org/10.1111/j.1365-2672.2010.04824.x
doi: 10.1111/j.1365-2672.2010.04824.x pubmed: 21070516

Auteurs

Ivana Rabbone (I)

S.S.V.D. Endocrinologia E Diabetologia, O.I.R.M., A.O. Città Della Salute E Della Scienza Di Torino, Turin, Italy.
Department of Health Science, UPO University A.O.U., ''Maggiore Della Carità'', Novara, Italy.

Deborah Traversi (D)

Department of Public Health and Pediatrics, University of Study of Torino, Piazza Polonia 94, 10126, Turin, Italy. deborah.traversi@unito.it.

Giacomo Scaioli (G)

Department of Public Health and Pediatrics, University of Study of Torino, Piazza Polonia 94, 10126, Turin, Italy.

Camilla Vallini (C)

S.S.V.D. Endocrinologia E Diabetologia, O.I.R.M., A.O. Città Della Salute E Della Scienza Di Torino, Turin, Italy.

Giulia Carletto (G)

Department of Public Health and Pediatrics, University of Study of Torino, Piazza Polonia 94, 10126, Turin, Italy.

Irene Masante (I)

Department of Public Health and Pediatrics, University of Study of Torino, Piazza Polonia 94, 10126, Turin, Italy.

Marilena Durazzo (M)

S.C.U Medicina Interna 3, Molinette Hospital, Città Della Salute E Della Scienza Di Torino, rin, Italy.

Alessandro Collo (A)

S.C.U Medicina Interna 3, Molinette Hospital, Città Della Salute E Della Scienza Di Torino, rin, Italy.

Paola Belci (P)

S.C.U Medicina Interna 3, Molinette Hospital, Città Della Salute E Della Scienza Di Torino, rin, Italy.

Arianna Ferro (A)

S.C.U Medicina Interna 3, Molinette Hospital, Città Della Salute E Della Scienza Di Torino, rin, Italy.

Francesco Cadario (F)

Department of Health Science, UPO University A.O.U., ''Maggiore Della Carità'', Novara, Italy.

Silvia Savastio (S)

Department of Health Science, UPO University A.O.U., ''Maggiore Della Carità'', Novara, Italy.

Deborah Carrera (D)

Department of Health Science, UPO University A.O.U., ''Maggiore Della Carità'', Novara, Italy.

Franco Cerutti (F)

Department of Public Health and Pediatrics, University of Study of Torino, Piazza Polonia 94, 10126, Turin, Italy.
S.S.V.D. Endocrinologia E Diabetologia, O.I.R.M., A.O. Città Della Salute E Della Scienza Di Torino, Turin, Italy.

Roberta Siliquini (R)

Department of Public Health and Pediatrics, University of Study of Torino, Piazza Polonia 94, 10126, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH